NASDAQ:RDNT

RadNet (RDNT) Stock Forecast, Price & News

$28.19

-0.51 (-1.78%)

(As of 09/29/2023 ET)

Compare

Today's Range: $27.86
▼
$28.87
50-Day Range: $27.30
▼
$34.47
52-Week Range: $12.03
▼
$35.18

Volume: 823,875 shs
Average Volume: 563,613 shs
Market Capitalization: $1.91 billion

P/E Ratio: N/A
Dividend Yield: N/A
Price Target: $33.33

RadNet MarketRank™ Forecast

Analyst Rating: Buy
3.00 Rating Score
Upside/Downside: 18.2% Upside
$33.33 Price Target
Short Interest: Healthy
2.48% of Shares Sold Short
Dividend Strength: N/A
Sustainability: -0.52
Upright™ Environmental Score
News Sentiment: N/A
Insider Trading: N/A
Proj. Earnings Growth: 7.89%
From $0.38 to $0.41 Per Share

Overall MarketRank^™

MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.

2.15 out of 5 stars

Medical Sector

481st out of 972 stocks

Medical Laboratories Industry

13th out of 25 stocks

2.5

Analyst's Opinion

Consensus Rating
RadNet has received a consensus rating of Buy. The company's average rating score is 3.00, and is based on 3 buy ratings, no hold ratings, and no sell ratings.
Price Target Upside/Downside
According to analysts' consensus price target of $33.33, RadNet has a forecasted upside of 18.2% from its current price of $28.19.
Amount of Analyst Coverage
RadNet has only been the subject of 1 research reports in the past 90 days.

3.0

Short Interest

Percentage of Shares Shorted
2.48% of the outstanding shares of RadNet have been sold short.
Short Interest Ratio / Days to Cover
RadNet has a short interest ratio ("days to cover") of 3.1, which is generally considered an acceptable ratio of short interest to trading volume.
Change versus previous month
Short interest in RadNet has recently increased by 0.60%, indicating that investor sentiment is decreasing.

0.0

Dividend Strength

Dividend Yield
RadNet does not currently pay a dividend.
Dividend Growth
RadNet does not have a long track record of dividend growth.

4.6

Sustainability and ESG

Overall ESG (Environmental, Social, and Governance) Score
RadNet has received a 72.34% net impact score from Upright. The largest positive contribution comes from its "Physical diseases" impact, which is mostly driven by its "Mammography services ", "Nuclear medicine imaging services", and "MRI services" products. See details.
Environmental Sustainability
The Environmental Impact score for RadNet is -0.52.

2.2

News and Social Media Coverage

News Sentiment
RadNet has a news sentiment score of 0.93. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 0.69 average news sentiment score of Medical companies.
News Coverage This Week
MarketBeat has tracked 1 news article for RadNet this week, compared to 2 articles on an average week.
Search Interest
Only 3 people have searched for RDNT on MarketBeat in the last 30 days. This is a decrease of 0% compared to the previous 30 days.

1.7

Company Ownership

Insider Buying vs. Insider Selling
In the past three months, RadNet insiders have not sold or bought any company stock.
Percentage Held by Insiders
Only 4.43% of the stock of RadNet is held by insiders.
Percentage Held by Institutions
74.84% of the stock of RadNet is held by institutions. High institutional ownership can be a signal of strong market trust in this company.

1.3

Earnings and Valuation

Earnings Growth
Earnings for RadNet are expected to grow by 7.89% in the coming year, from $0.38 to $0.41 per share.
Price to Earnings Ratio vs. the Market
The P/E ratio of RadNet is -112.76, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.
Price to Earnings Ratio vs. Sector
The P/E ratio of RadNet is -112.76, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.
Price to Book Value per Share Ratio
RadNet has a P/B Ratio of 3.29. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities.

See Top Rated MarketRank™ Stocks Here

About RadNet (NASDAQ:RDNT) Stock

RadNet, Inc., together with its subsidiaries, provides outpatient diagnostic imaging services in the United States. The company operates in two segments: Imaging Centers and Artificial Intelligence. Its services include magnetic resonance imaging, computed tomography, positron emission tomography, nuclear medicine, mammography, ultrasound, diagnostic radiology, fluoroscopy, and other related procedures, as well as multi-modality imaging services. The company also develops and sells computerized systems that distribute, display, store, and retrieve digital images; offers picture archiving communications systems and related services; and develops and deploys AI suites to enhance radiologist interpretation of breast, lung, and prostate images, as well as AI solutions for prostate cancer screening. RadNet, Inc. was founded in 1981 and is headquartered in Los Angeles, California.

RDNT Price History

30 days | 90 days | 365 days | Advanced Chart

RDNT Stock News Headlines

September 20, 2023 | finance.yahoo.com

RadNet, Inc. to Present at the Sidoti & Company Fall 2023 Virtual Conference on Wednesday, September 20th

August 31, 2023 | finance.yahoo.com

Be Wary Of RadNet (NASDAQ:RDNT) And Its Returns On Capital

October 1, 2023 | Chaikin Analytics (Ad)

This is the #1 Stock to Buy for the AI Tidal Wave

Marc Chaikin warned people about NVDA before its 2023 bull run - now he’s naming his next pick or the AI tidal wave. Learn more here.

August 24, 2023 | markets.businessinsider.com

Jim Cramer Says This Major Telecom Stock Is 'Horrendous'

August 8, 2023 | finance.yahoo.com

RadNet (RDNT) Q2 Earnings and Revenues Top Estimates

August 8, 2023 | benzinga.com

A Preview Of RadNet's Earnings

August 8, 2023 | finance.yahoo.com

RadNet Reports Second Quarter Financial Results, with Record Quarterly Revenue and Adjusted EBITDA(1), and Updates 2023 Financial Guidance Ranges

July 31, 2023 | finance.yahoo.com

RadNet, Inc. Announces the Addition of Sham Sokka and Sanjog Misra to Drive Further Growth Within its Digital Health Initiatives

October 1, 2023 | Chaikin Analytics (Ad)

This is the #1 Stock to Buy for the AI Tidal Wave

Marc Chaikin warned people about NVDA before its 2023 bull run - now he’s naming his next pick or the AI tidal wave. Learn more here.

July 21, 2023 | finance.yahoo.com

RadNet, Inc. Announces Date of its Second Quarter 2023 Financial Results Conference Call

July 18, 2023 | markets.businessinsider.com

Jim Cramer Says 'Hats Off To Jamie Dimon': Why He's Bullish On JPMorgan

July 17, 2023 | msn.com

RadNet: Growing Procedure Volumes - Significant Upside Potential

June 16, 2023 | finance.yahoo.com

RadNet Announces Closing Of Upsized Public Offering Of Common Stock

June 14, 2023 | markets.businessinsider.com

Why RadNet (RDNT) Stock Is Getting Hammered

June 14, 2023 | marketwatch.com

RadNet Shares Fall After Pricing Stock Offering

June 14, 2023 | msn.com

MicroVision, RadNet And Other Big Stocks Moving Lower In Wednesday's Pre-Market Session

June 14, 2023 | msn.com

RadNet shares slide on pricing upsized $225M stock offering

June 14, 2023 | finance.yahoo.com

RadNet Announces Pricing of Upsized Public Offering of Common Stock

June 13, 2023 | benzinga.com

RadNet shares are trading lower after the company announced a proposed $475 million underwritten public offering of common stock.

June 13, 2023 | finance.yahoo.com

RADNET ANNOUNCES PROPOSED $175 MILLION UNDERWRITTEN PUBLIC OFFERING OF COMMON STOCK

June 5, 2023 | finance.yahoo.com

RadNet, Inc. to Present at the Jefferies 2023 Global Healthcare Conference on June 8, 2023

May 24, 2023 | finance.yahoo.com

Are Investors Undervaluing RadNet, Inc. (NASDAQ:RDNT) By 42%?

May 13, 2023 | seekingalpha.com

RadNet, Inc. (RDNT) Q1 2023 Earnings Call Transcript

May 12, 2023 | msn.com

Raymond James Maintains Radnet (RDNT) Outperform Recommendation

May 10, 2023 | markets.businessinsider.com

Raymond James Keeps Their Buy Rating on Radnet (RDNT)

May 9, 2023 | markets.businessinsider.com

RadNet earnings: here's what Wall Street expects

May 4, 2023 | finance.yahoo.com

Maryland Governor Moore Signs RadNet-supported Legislation to Make Follow-up Diagnostic Imaging for Breast and Lung Cancers More Affordable

See More Headlines

Receive RDNT Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for RadNet and its competitors with MarketBeat's FREE daily newsletter.

RDNT Company Calendar

Last Earnings: 8/08/2023
Today: 10/01/2023
Next Earnings (Estimated): 11/08/2023
Fiscal Year End: 12/31/2023

Get Stock Alerts

Industry, Sector and Symbol

Stock Exchange: NASDAQ
Industry: Medical laboratories
Sub-Industry: N/A
Sector: Medical
Current Symbol: NASDAQ:RDNT
CUSIP: N/A
CIK: 790526
Web: www.radnet.com
Phone: (310) 445-2800
Fax: 310-445-2980
Employees: 9,067
Year Founded: 1980

Price Target and Rating

Average Stock Price Forecast: $33.33
High Stock Price Forecast: $40.00
Low Stock Price Forecast: $30.00
Forecasted Upside/Downside: +18.2%
Consensus Rating: Buy
Rating Score (0-4): 3.00
Research Coverage: 3 Analysts

Profitability

EPS (Most Recent Fiscal Year): ($0.25)
Trailing P/E Ratio: N/A
Forward P/E Ratio: 74.18
P/E Growth: N/A
Net Income: $10.65 million
Net Margins: -0.84%
Pretax Margin: 1.09%
Return on Equity: 3.98%
Return on Assets: 0.89%

Debt

Debt-to-Equity Ratio: 1.11
Current Ratio: 1.39
Quick Ratio: 1.39

Sales & Book Value

Annual Sales: $1.43 billion
Price / Sales: 1.34
Cash Flow: $3.48 per share
Price / Cash Flow: 8.10
Book Value: $8.57 per share
Price / Book: 3.29

Miscellaneous

Outstanding Shares: 67,770,000
Free Float: 64,771,000
Market Cap: $1.91 billion
Optionable: Optionable
Beta: 1.68

Social Links

The Best High-Yield Dividend Stocks for 2023

Looking to generate income with your stock portfolio? Use these ten stocks to generate a safe and reliable source of investment income.

Get This Free Report

Key Executives

Dr. Howard G. Berger M.D. (Age 77)
Chairman, Pres & CEO
Comp: $5.56M

Mr. Mark D. Stolper (Age 52)
Exec. VP & CFO
Comp: $1.13M

Mr. Mital Patel (Age 37)
Exec. VP of Financial Planning & Analysis and Chief Admin. Officer
Comp: $1.15M

Mr. Norman R. Hames (Age 67)
Pres & COO of Western Operations
Comp: $1.28M

Mr. Stephen M. Forthuber (Age 62)
Pres & COO of Eastern Operations
Comp: $1.3M

Ms. Christine Nayoma Gordon (Age 60)
Sr. VP of Operations - Northern California & Director
Comp: $384.38k

Mr. Ranjan Jayanathan (Age 67)
Exec. VP, Chief Information Officer & GM of eRAD - Radiology Information Technology Division

Dr. Gregory Sorensen M.D. (Age 61)
Exec. VP, Chief Science Officer & Director

Ms. Laura Foster BSRT
MPH, J.D., Sr. VP of Compliance & Regulatory Affairs

Mr. David Jeffrey Katz (Age 58)
Exec. VP, Chief Legal Officer & Corp. Sec.

Key Competitors

View All Competitors

Insiders & Institutions

View All Insider Transactions
View All Institutional Transactions

RDNT Stock - Frequently Asked Questions

Should I buy or sell RadNet stock right now?: 3 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for RadNet in the last year. There are currently 3 buy ratings for the stock. The consensus among Wall Street equities research analysts is that investors should "buy" RDNT shares.
View RDNT analyst ratings or view top-rated stocks.
What is RadNet's stock price forecast for 2023?: 3 brokerages have issued 1-year price objectives for RadNet's stock. Their RDNT share price forecasts range from $30.00 to $40.00. On average, they anticipate the company's share price to reach $33.33 in the next year. This suggests a possible upside of 18.2% from the stock's current price.
View analysts price targets for RDNT or view top-rated stocks among Wall Street analysts.
How have RDNT shares performed in 2023?: RadNet's stock was trading at $18.83 at the beginning of 2023. Since then, RDNT stock has increased by 49.7% and is now trading at $28.19.
View the best growth stocks for 2023 here.
When is RadNet's next earnings date?: The company is scheduled to release its next quarterly earnings announcement on Wednesday, November 8th 2023.
View our RDNT earnings forecast.
How were RadNet's earnings last quarter?: RadNet, Inc. (NASDAQ:RDNT) issued its quarterly earnings results on Tuesday, August, 8th. The medical research company reported $0.24 earnings per share for the quarter, topping analysts' consensus estimates of $0.07 by $0.17. The medical research company had revenue of $403.70 million for the quarter, compared to the consensus estimate of $389.29 million. RadNet had a negative net margin of 0.84% and a positive trailing twelve-month return on equity of 3.98%. The firm's revenue for the quarter was up 13.9% compared to the same quarter last year. During the same period in the prior year, the company earned $0.15 earnings per share.
What ETFs hold RadNet's stock?: ETFs with the largest weight of RadNet (NASDAQ:RDNT) stock in their portfolio include Invesco S&P SmallCap Health Care ETF (PSCH), SPDR S&P Health Care Services ETF (XHS), Invesco Dorsey Wright Healthcare Momentum ETF (PTH) and First Trust Small Cap Growth AlphaDEX Fund (FYC).iShares U.S. Healthcare Providers ETF (IHF).
What guidance has RadNet issued on next quarter's earnings?: RadNet issued an update on its FY 2023 earnings guidance on Tuesday, August, 8th. The company provided EPS guidance of for the period. The company issued revenue guidance of $1.57 billion-$1.61 billion, compared to the consensus revenue estimate of $1.54 billion.

What is Howard G. Berger's approval rating as RadNet's CEO?: 174 employees have rated RadNet Chief Executive Officer Howard G. Berger on Glassdoor.com. Howard G. Berger has an approval rating of 45% among the company's employees. This puts Howard G. Berger in the bottom 10% of approval ratings compared to other CEOs of publicly-traded companies.
What other stocks do shareholders of RadNet own?: Based on aggregate information from My MarketBeat watchlists, some companies that other RadNet investors own include Advanced Micro Devices (AMD), AbbVie (ABBV), Inovio Pharmaceuticals (INO), NVIDIA (NVDA), OPKO Health (OPK), Boeing (BA), Rigel Pharmaceuticals (RIGL), UnitedHealth Group (UNH), Pfizer (PFE) and AT&T (T).
What is RadNet's stock symbol?: RadNet trades on the NASDAQ under the ticker symbol "RDNT."
How do I buy shares of RadNet?: Shares of RDNT stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.
What is RadNet's stock price today?: One share of RDNT stock can currently be purchased for approximately $28.19.
How much money does RadNet make?: RadNet (NASDAQ:RDNT) has a market capitalization of $1.91 billion and generates $1.43 billion in revenue each year. The medical research company earns $10.65 million in net income (profit) each year or ($0.25) on an earnings per share basis.
How many employees does RadNet have?: The company employs 9,067 workers across the globe.
How can I contact RadNet?: RadNet's mailing address is 1510 COTNER AVE, LOS ANGELES CA, 90025. The official website for the company is www.radnet.com. The medical research company can be reached via phone at (310) 445-2800, via email at investorrelations@radnet.com, or via fax at 310-445-2980.

This page (NASDAQ:RDNT) was last updated on 10/1/2023 by MarketBeat.com Staff

Get 30 Days of MarketBeat All Access Free

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your 30-Day Free Trial